ERYTECH reports financial highlights for Q4 2014 and updates on upcoming milestones Post author:admERY Post published:February 10, 2015 Post category:Newsroom ERYTECH reports revenues and cash balance for the fourth quarter of 2014 and provides an update on upcoming milestones. You Might Also Like ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017 ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting June 1, 2020 ERYTECH Achieves Milestones in TRYbeCA1 Phase 3 Trial of Eryaspase in Second-line Pancreatic Cancer November 4, 2019
ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017
ERYTECH Achieves Milestones in TRYbeCA1 Phase 3 Trial of Eryaspase in Second-line Pancreatic Cancer November 4, 2019
